LENZ
LENZ Therapeutics
LENZ
LENZ
63 hedge funds and large institutions have $91.2M invested in LENZ Therapeutics in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
0.17% less ownership
Funds ownership: 7.44% → 7.27% (-0.17%)
Holders
63
Holding in Top 10
1
Calls
$507K
Puts
$406K
Top Buyers
| 1 | +$2.74M | |
| 2 | +$1.33M | |
| 3 | +$1.13M | |
| 4 |
PFMU
Privium Fund Management (UK)
London,
United Kingdom
|
+$699K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$432K |
Top Sellers
| 1 | -$2.2M | |
| 2 | -$1.12M | |
| 3 | -$1.1M | |
| 4 |
Renaissance Technologies
New York
|
-$841K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$825K |